Cargando…

Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH

Large-scale genome-wide SNP association studies have identified an association between variants of CR1, the gene encoding complement component receptor 1, and the sporadic form of Alzheimer's disease. The role of CR1 and the complement system in Alzheimer's disease remains far from clear....

Descripción completa

Detalles Bibliográficos
Autores principales:	Killick, R., Hughes, T.R., Morgan, B.P., Lovestone, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers Ireland 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556777/ https://www.ncbi.nlm.nih.gov/pubmed/23153828 http://dx.doi.org/10.1016/j.neulet.2012.11.008

Ejemplares similares

Corrigendum to “Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH” [Neurosci. Lett. 533 (2013) 96–99]
por: Killick, R., et al.
Publicado: (2013)

Structures of the rat complement regulator CrrY
por: Roversi, Pietro, et al.
Publicado: (2011)

p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells
por: Hooper, Claudie, et al.
Publicado: (2007)

Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1
Publicado: (1992)

The Importance of Tau Phosphorylation for Neurodegenerative Diseases
por: Noble, Wendy, et al.
Publicado: (2013)

Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia reperfusion injury
por: Miao, Jing, et al.
Publicado: (2014)

Expression of Membrane Complement Regulatory Proteins Crry and CD55 in Normal Rats
por: Kato, Chie, et al.
Publicado: (2013)

Associations of CFH Polymorphisms and CFHR1-CFHR3 Deletion with Blood Pressure and Hypertension in Chinese Population
por: Gan, Wei, et al.
Publicado: (2012)

Crry silencing alleviates Alzheimer’s disease injury by regulating neuroinflammatory cytokines and the complement system
por: Zhu, Xi-Chen, et al.
Publicado: (2022)

Expression dynamics of Crry at the implantation sites in normal pregnancy and response against miscarriage induction
por: KUNIYOSHI, Nobue, et al.
Publicado: (2022)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
por: Startin, Carla M., et al.
Publicado: (2019)

Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones
por: Nagano, Fumihiko, et al.
Publicado: (2021)

Influence of CFH gene on symptom severity of schizophrenia
por: Zhang, Chen, et al.
Publicado: (2017)

Prevention of experimental autoimmune myasthenia gravis by rat Crry-Ig: A model agent for long-term complement inhibition in vivo
por: Hepburn, Natalie J., et al.
Publicado: (2008)

Molecular Docking and Molecular Dynamics (MD) Simulation of Human Anti-Complement Factor H (CFH) Antibody Ab42 and CFH Polypeptide
por: Yang, Bing, et al.
Publicado: (2019)

Complement inhibitor Crry expression in mouse placenta is essential for maintaining normal blood pressure and fetal growth
por: Banadakoppa, Manu, et al.
Publicado: (2020)

Deletion of the murine ortholog of human 9p21.3 locus promotes atherosclerosis by increasing macrophage proinflammatory activity
por: Kettunen, Sanna, et al.
Publicado: (2023)

Complement Component 5 (C5) Deficiency Improves Cognitive Outcome After Traumatic Brain Injury and Enhances Treatment Effects of Complement Inhibitors C1-Inh and CR2-Crry in a Mouse Model
por: Chen, Min, et al.
Publicado: (2023)

Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis
por: Soltys, Jindrich, et al.
Publicado: (2012)

Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer models
por: Homer-Bouthiette, Collin, et al.
Publicado: (2018)

Atypical HUS Associated with CFH/CFHR-1 Hybrid Gene
por: Negi, Sharon, et al.
Publicado: (2020)

Exogenous CFH Modulates Levels of Pro-Inflammatory Mediators to Prevent Oxidative Damage of Retinal Pigment Epithelial Cells with the At-Risk CFH Y402H Variant
por: Velazquez-Soto, Henry, et al.
Publicado: (2023)

Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer’s Disease
por: Hermann, Peter, et al.
Publicado: (2022)

Transgenic Mice Overexpressing the Complement Inhibitor Crry as a Soluble Protein Are Protected from Antibody-induced Glomerular Injury
por: Quigg, Richard J., et al.
Publicado: (1998)

Dapagliflozin Ameliorates Diabetic Kidney Disease via Upregulating Crry and Alleviating Complement Over-activation in db/db Mice
por: Chang, Dong-Yuan, et al.
Publicado: (2021)

Genetic analysis of CFH and MCP in Egyptian patients with immune-complex proliferative glomerulonephritis
por: Gouda, Heba R., et al.
Publicado: (2022)

Interleukin 27 Induces the Expression of Complement Factor H (CFH) in the Retina
por: Amadi-Obi, Ahjoku, et al.
Publicado: (2012)

A Tangled Web – Tau and Sporadic Parkinson's Disease
por: Wray, Selina, et al.
Publicado: (2010)

The ε3 and ε4 Alleles of Human APOE Differentially Affect Tau Phosphorylation in Hyperinsulinemic and Pioglitazone Treated Mice
por: To, Alvina W. M., et al.
Publicado: (2011)

Neovascular Age-Related Macular Degeneration Risk Based on CFH, LOC387715/HTRA1, and Smoking
por: Hughes, Anne E, et al.
Publicado: (2007)

The GSK3 hypothesis of Alzheimer's disease
por: Hooper, Claudie, et al.
Publicado: (2008)

Tissue-specific phosphorylation of complement receptors CR1 and CR2
Publicado: (1986)

Association of CFH and CFB Gene Polymorphisms with Retinopathy in Type 2 Diabetic Patients
por: Wang, Jun, et al.
Publicado: (2013)

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies
por: Münch, Johannes, et al.
Publicado: (2017)

Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease
por: Arnsten, Amy F. T., et al.
Publicado: (2020)

CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD
por: Bukanov, Nikolay O., et al.
Publicado: (2012)

The Evolution of Tau Phosphorylation and Interactions
por: Trushina, Nataliya I., et al.
Publicado: (2019)

Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients
por: McCormack, Mark, et al.
Publicado: (2018)

Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein
Publicado: (1995)

Induced neural stem cell grafts exert neuroprotection through an interaction between Crry and Akt in a mouse model of closed head injury
por: Gao, Mou, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hjbotk2cfipk1a01lfn567q0i3